2Flo Ventures’ Post

📣 Thank you to Loop Capital for sponsoring 2Flo Ventures’ Health Equity Investing Symposium! Your support helps make this important event possible as we work to drive impactful solutions in healthcare. 💡 Loop Capital's Partner and Head of Corporate Investment Banking, Sidney Dillard will represent the company and share her expertise on the “Investing in Health Equity” panel. Your insights are crucial as we explore how to create more opportunities for diverse investors and make meaningful progress in health equity. Join the conversation on September 12th. Register today! 🔜 https://bit.ly/3Wy1K5V #HealthEquity #ImpactInvesting #LoopCapital #2FloEquity #InvestingForChange

📣 We are thrilled to announce the “Investing in Health Equity” session at 2Flo Ventures' Health Equity Investing Symposium on September 12th! This discussion, moderated by Patrick Walsh, MBA, will feature Sidney Dillard, MBA, Heath Naquin, and Michelle Burbea Hoffmann, PhD. Join us for a conversation that explores how to make equity-focused investing more impactful! Register here 👉 https://bit.ly/3Wy1K5V #HealthEquity #ImpactInvesting #2FloEquity #InclusiveInnovation

🚨 We’re just ONE WEEK away from the 2Flo Ventures Health Equity Investing Symposium 2024! 🚨 Join us as we bring together industry leaders, investors, and healthcare innovators to explore how we can advance health equity through investing and innovation! Don’t miss out on this exciting opportunity to network, learn, and join the movement to create a lasting impact! ➡ Reserve your spot today: https://bit.ly/3Wy1K5V #HealthEquity #Innovation #VentureCapital #2FloEquity #ImpactInvesting

Join us for the “Industry and Health Equity” session at 2Flo Ventures' Health Equity Investing Symposium! Moderated by Azurii K. Collier, Ph.D., this dynamic panel features Rose Blackburne, MD, MBA, Marisa Campbell, and Kalahn Taylor-Clark, PhD, MPH. Together, they will explore the industry's role in advancing health equity and how leaders across sectors drive impactful solutions to reduce disparities. Don’t miss this opportunity to learn how industry innovators are shaping a more equitable healthcare landscape! Register here ➡  https://bit.ly/3Wy1K5V

📣 We’re excited to announce the upcoming session, "Perspective on Health Equity from Payers and Providers," at 2Flo Ventures' Health Equity Investing Symposium! This insightful discussion will be moderated by Garth N. Walker, MD, MPH, Chief Medical Officer at Rush Health & Assistant Professor of Emergency Medicine at Rush University System for Health, and will feature an esteemed panel, including ▶ Charles DeShazer, M.D. | Chief Quality & Health Advocacy Officer at Cigna Healthcare ▶ Opella Ernest M.D. | President, HCSC Markets at Health Care Service Corporation ▶ Rushil Desai | President & CEO at Aetna, a CVS Health Company Together, they will explore how payers and providers can collaborate to drive meaningful change in health equity. Don’t miss this opportunity to gain valuable insights into the strategies and innovations shaping the future of equitable healthcare. Register here ➡  https://bit.ly/3Wy1K5V #HealthEquity #HealthcareInnovation #InvestingForImpact #2FloEquity

🏆Dr. Ngozi Ezike | Health Equity Titan Of The Year🏆 We are thrilled to recognize Ngozi Ezike as this year’s 2Flo Ventures Health Equity Titan of the Year! With a distinguished career dedicated to advancing health equity, Dr. Ezike has relentlessly advocated for underserved communities. From her pivotal role as the President and CEO of Sinai Chicago, to her leadership during the COVID-19 pandemic as the Director of the Illinois Department of Public Health (IDPH), Dr. Ezike has consistently championed initiatives that ensure equitable healthcare access for all. We are honored to have Dr. Ezike as the keynote speaker at the upcoming 2Flo Ventures Health Equity Investing Symposium. Her insights on the intersection of healthcare innovation and equity will undoubtedly inspire and inform our work in this critical area. Moderating this impactful session will be Ramona Burress, PharmD, MBA, Global Head of Patient Engagement and Insights at Takeda Pharmaceuticals. With over two decades of experience as a clinical pharmacist and a leader in healthcare delivery and drug development, Ramona has been a driving force in promoting patient outcomes and equity in healthcare. Her career reflects a deep commitment to bridging the gap between scientific innovation and the communities who benefit most. ➡ Join us for an engaging discussion that promises to be a highlight of the symposium! Thank you to our sponsors Latham & Watkins, Women of Color in Pharma (WOCIP), Cooley LLP, Venture Best®, and CBRE for supporting this award and event! #HealthEquity #2FloEquity #HealthcareInnovation #InvestingInEquity #2FloVentures